In December, The Conversation hosted a webinar on AI's revolutionary role in drug discovery and development. Science and ...

A compound found in python blood could lead to a new kind of weight loss drug, one that suppresses appetite without some of the side effects linked to popular medications like Ozempic. Map shows next ...

Application Covering 64 SKUs Clears FDA Filing Review, Poised to Enter the Final Regulatory Phase Prior to a Marketing Order Decision AUSTIN, Texas--(BUSINESS WIRE)--Sesh Products US, Inc. (Sesh) ...

As demand for GLP-1 weight loss drugs skyrockets, so does the risk of getting scammed. What we've been seeing in our scam tracker is advertisements about supplements that work just as well as *** ...

CINCINNATI (WXIX) - President Trump made remarks and toured Thermo Fisher Scientific in Reading Wednesday as part of a his push to lower drug prescription prices. Thermo Fischer Scientific is a ...

The FDA on Tuesday approved leucovorin as a treatment for a rare genetic condition, not for autism, as the Trump administration had suggested The U.S. Food and Drug Administration on Tuesday approved ...

People who order low-cost versions of the wildly popular weight-loss drugs Wegovy and Zepbound from so-called compounding pharmacies might soon see disruptions in their medication. The U.S. Food and ...

Recent regulatory setbacks, especially involving Asia-centric trials, underscore the consequences of insufficient regional planning. Emerging statistical approaches, including adaptive and Bayesian ...

OpenAI is releasing a new app called Prism today, and it hopes it does for science what coding agents like Claude Code and its own Codex platform have done for programming. Prism builds on Crixet, a ...

Prism is a ChatGPT-powered text editor that automates much of the work involved in writing scientific papers. OpenAI just revealed what its new in-house team, OpenAI for Science, has been up to. The ...